|
US6458772B1
(en)
*
|
1909-10-07 |
2002-10-01 |
Medivir Ab |
Prodrugs
|
|
GB8725939D0
(en)
*
|
1987-11-05 |
1987-12-09 |
Wellcome Found |
Therapeutic compounds
|
|
GB8829571D0
(en)
*
|
1988-12-19 |
1989-02-08 |
Wellcome Found |
Antiviral compounds
|
|
US5677308A
(en)
*
|
1996-12-19 |
1997-10-14 |
Lerner; A. Martin |
Method for alleviating spasmodic torticollis
|
|
US6399622B1
(en)
|
1997-02-18 |
2002-06-04 |
A. Martin Lerner |
Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
|
|
US5872123A
(en)
*
|
1997-02-18 |
1999-02-16 |
Lerner; A. Martin |
Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
|
|
US6537997B1
(en)
|
1997-02-18 |
2003-03-25 |
A. Martin Lerner |
Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
|
|
CN1130362C
(zh)
*
|
1997-08-15 |
2003-12-10 |
美迪维尔公司 |
核苷类似物,这些化合物作为包括乙型肝炎病毒(hbv)的逆转录病毒的逆转录酶及dna聚合酶抑制剂的抗病毒药
|
|
US20020128301A1
(en)
*
|
1998-02-13 |
2002-09-12 |
Medivir AB |
Non-nucleoside reverse transcriptase inhibitors
|
|
US6444652B1
(en)
|
1998-08-10 |
2002-09-03 |
Novirio Pharmaceuticals Limited |
β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
|
|
SG132498A1
(en)
|
1998-08-10 |
2007-06-28 |
Idenix Pharmaceuticals Inc |
Beta-l-2æ-deoxy-nucleosides for the treatment of hepatitis b
|
|
US6107303A
(en)
*
|
1999-03-15 |
2000-08-22 |
Demarco; Charlene C. |
Treatment of Epstein Barr infection
|
|
US6448256B1
(en)
|
1999-05-24 |
2002-09-10 |
University Of Massachusetts |
Antibiotic prodrugs
|
|
GB0010446D0
(en)
*
|
2000-04-28 |
2000-06-14 |
Glaxo Wellcome Kk |
Pharmaceutical formulation
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
NZ547204A
(en)
|
2000-05-26 |
2008-01-31 |
Idenix Cayman Ltd |
Methods and compositions for treating flaviviruses and pestiviruses
|
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
|
US6875751B2
(en)
*
|
2000-06-15 |
2005-04-05 |
Idenix Pharmaceuticals, Inc. |
3′-prodrugs of 2′-deoxy-β-L-nucleosides
|
|
US20030212051A1
(en)
*
|
2001-04-06 |
2003-11-13 |
Polli James E |
Bile acid containing prodrugs with enhanced bioavailabilty
|
|
CA2457835A1
(en)
*
|
2001-09-07 |
2003-03-20 |
Teva Pharmaceutical Industries Ltd. |
Crystalline forms of valacyclovir hydrochloride
|
|
US7138376B2
(en)
*
|
2001-09-28 |
2006-11-21 |
Idenix Pharmaceuticals, Inc. |
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
|
|
US20040197396A1
(en)
*
|
2001-11-05 |
2004-10-07 |
Fain Helen S |
Anhydrous crystal form of valaciclovir hydrochloride
|
|
CN1307177C
(zh)
|
2001-11-14 |
2007-03-28 |
特瓦制药工业有限公司 |
伐昔洛韦的合成与纯化
|
|
JP2005519916A
(ja)
*
|
2001-12-14 |
2005-07-07 |
フアーマセツト・リミテツド |
ウィルス感染治療用ｎ４−アシルシトシンヌクレオシド類
|
|
CA2470938A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Raymond F. Schinazi |
Treatment of ebv and khsv infection and associated abnormal cellular proliferation
|
|
SE521676C2
(sv)
*
|
2002-01-02 |
2003-11-25 |
Dilafor Ab |
Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
|
|
NZ534811A
(en)
*
|
2002-02-14 |
2007-07-27 |
Pharmasset Inc |
Modified fluorinated nucleoside analogues
|
|
AU2003217676B2
(en)
|
2002-02-22 |
2009-06-11 |
Takeda Pharmaceutical Company Limited |
Active agent delivery systems and methods for protecting and administering active agents
|
|
AU2003240213A1
(en)
*
|
2002-06-24 |
2004-01-06 |
Ranbaxy Laboratories Limited |
Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
|
|
MY140819A
(en)
|
2002-06-28 |
2010-01-29 |
Idenix Caymans Ltd |
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
|
|
AU2003248748A1
(en)
|
2002-06-28 |
2004-01-19 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
AU2003263412A1
(en)
|
2002-06-28 |
2004-01-19 |
Centre National De La Recherche Scientifique (Cnrs) |
1'-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
|
|
US7608600B2
(en)
*
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
TWI244393B
(en)
|
2002-08-06 |
2005-12-01 |
Idenix Pharmaceuticals Inc |
Crystalline and amorphous forms of beta-L-2'-deoxythymidine
|
|
US20050043329A1
(en)
*
|
2002-09-06 |
2005-02-24 |
Shlomit Wizel |
Crystalline forms of valacyclovir hydrochloride
|
|
BR0314259A
(pt)
*
|
2002-09-13 |
2005-07-26 |
Idenix Cayman Ltd |
ß-l-2'-desoxinucleosìdeos para o tratamento de cepas de hbv resistentes e terapias combinadas
|
|
WO2004035583A1
(en)
*
|
2002-10-16 |
2004-04-29 |
Teva Pharmaceutical Industries Ltd. |
Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
|
|
CN1319972C
(zh)
*
|
2002-10-16 |
2007-06-06 |
特瓦制药工业有限公司 |
在盐酸伐昔洛韦结晶中减少残留醇类物质的方法
|
|
US20050059684A1
(en)
*
|
2002-10-16 |
2005-03-17 |
Ben-Zion Dolitzky |
Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
|
|
US7824851B2
(en)
|
2002-11-15 |
2010-11-02 |
Idenix Pharmaceuticals, Inc. |
2′-branched nucleosides and Flaviviridae mutation
|
|
TWI332507B
(en)
*
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
|
EP1575953A1
(en)
*
|
2002-12-09 |
2005-09-21 |
Texcontor Etablissement |
Anhydrous crystalline form of valacyclovir hydrochloride
|
|
AU2003296601A1
(en)
*
|
2002-12-10 |
2004-06-30 |
F. Hoffmann-La Roche Ag |
Antiviral nucleoside derivatives
|
|
KR20050109918A
(ko)
|
2002-12-12 |
2005-11-22 |
이데닉스 (케이만) 리미티드 |
2'-분지형 뉴클레오시드의 제조 방법
|
|
NZ540913A
(en)
*
|
2002-12-23 |
2008-02-29 |
Idenix Cayman Ltd |
Process for the production of 3'-nucleoside prodrugs
|
|
AU2004206821C1
(en)
|
2003-01-14 |
2009-10-01 |
Gilead Sciences, Inc. |
Compositions and methods for combination antiviral therapy
|
|
US7582748B2
(en)
*
|
2003-03-20 |
2009-09-01 |
Microbiologica Quimica E Farmaceutical Ltd. |
Methods of manufacture of 2′-deoxy-β-L-nucleosides
|
|
WO2004096149A2
(en)
*
|
2003-04-28 |
2004-11-11 |
Idenix (Cayman) Limited |
Industrially scalable nucleoside synthesis
|
|
AU2003232719A1
(en)
*
|
2003-05-30 |
2005-01-21 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Novel crystalline forms of valacyclovir hydrochloride
|
|
CA2734052A1
(en)
|
2003-05-30 |
2005-01-13 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
|
WO2005000850A2
(en)
|
2003-06-02 |
2005-01-06 |
Teva Pharmaceutical Industries, Ltd. |
Novel crystalline forms of valacyclovir hydrochloride
|
|
RU2361875C2
(ru)
*
|
2003-06-30 |
2009-07-20 |
Айденикс (Кайман) Лимитед |
СИНТЕЗ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
|
|
US20050025839A1
(en)
*
|
2003-07-28 |
2005-02-03 |
Polli James Edward |
Formulation approach to enhance transporter-mediated drug uptake
|
|
US20050137141A1
(en)
*
|
2003-10-24 |
2005-06-23 |
John Hilfinger |
Prodrug composition
|
|
US20070167353A1
(en)
*
|
2003-10-24 |
2007-07-19 |
John Hilfinger |
Prodrug composition
|
|
US7253175B2
(en)
*
|
2003-11-13 |
2007-08-07 |
Barnet Liberman |
Method for treating athlete's foot
|
|
CN1980657A
(zh)
|
2004-05-05 |
2007-06-13 |
耶鲁大学 |
新颖的抗病毒赛菊宁黄质类似物
|
|
BRPI0512360A
(pt)
*
|
2004-06-23 |
2008-03-11 |
Idenix Cayman Ltd |
derivados de 5-aza-7-deazapurina para o tratamento de flaviviridae
|
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
|
JP2007513074A
(ja)
*
|
2004-09-04 |
2007-05-24 |
テバ ファーマシューティカル インダストリーズ リミティド |
単離されたバラシクロビル不純物、バラシクロビル不純物の調製方法および参照標準としての使用
|
|
BRPI0515279A
(pt)
|
2004-09-14 |
2008-07-15 |
Pharmasset Inc |
preparação de ribofuranosil pirimidinas e purinas 2'fluoro-2'-alquil- substituìdas ou outras opcionalmente substituìdas e seus derivados
|
|
US20060178512A1
(en)
*
|
2005-02-04 |
2006-08-10 |
Cheruthur Govindan |
Method for preparing amino acid esters of nucleoside analogues
|
|
WO2006127217A2
(en)
|
2005-05-25 |
2006-11-30 |
Eli Lilly And Company |
Cyclopropanecarboxylate esters of acyclovir
|
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
TWI375560B
(en)
*
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
EP1746098A1
(en)
*
|
2005-07-21 |
2007-01-24 |
SOLMAG S.p.A. |
Valacyclovir polymorphs and a process for the preparation thereof
|
|
US20070112193A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Khunt Mayur D |
Valacyclovir process
|
|
WO2007075876A2
(en)
|
2005-12-23 |
2007-07-05 |
Idenix Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
|
GB0605344D0
(en)
*
|
2006-03-17 |
2006-04-26 |
Pliva Istrazivanje I Razvoj D |
Pharmaceutically acceptable salts and polymorphic forms
|
|
EP2068906B1
(en)
|
2006-09-19 |
2012-08-01 |
Sungkyunkwan University Foundation for Corporate Collaboration |
Antiviral agent against animal viruses
|
|
US20080167325A1
(en)
*
|
2006-12-27 |
2008-07-10 |
Bs Praveen Kumar |
Valacyclovir compositions
|
|
WO2008089008A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Biomarin Pharmaceutical Inc. |
Tetrahydrobiopterin prodrugs
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
US20080281099A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Mayur Devjibhai Khunt |
Process for purifying valacyclovir hydrochloride and intermediates thereof
|
|
US20090076039A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched valacyclovir
|
|
CN101969953B
(zh)
*
|
2008-01-03 |
2013-01-09 |
生物马林药物股份有限公司 |
用于治疗bh4反应性疾病的喋呤类似物
|
|
TW200946541A
(en)
*
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
|
US20110059921A1
(en)
*
|
2008-03-27 |
2011-03-10 |
Ektar Therapeutics |
Oligomer-Nitrogenous Base Conjugates
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
US8716262B2
(en)
*
|
2008-12-23 |
2014-05-06 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
EP2376514A2
(en)
*
|
2008-12-23 |
2011-10-19 |
Pharmasset, Inc. |
Nucleoside analogs
|
|
WO2010075554A1
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Synthesis of purine nucleosides
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI583692B
(zh)
*
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
RS54368B1
(sr)
|
2010-03-31 |
2016-04-28 |
Gilead Pharmasset Llc |
Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
CA2818853A1
(en)
|
2010-11-30 |
2012-06-07 |
Gilead Pharmasset Llc |
2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
|
|
CN102584825B
(zh)
*
|
2011-01-17 |
2014-04-02 |
四川科伦药物研究有限公司 |
一种合成盐酸伐昔洛韦的方法
|
|
WO2013076688A1
(en)
*
|
2011-11-25 |
2013-05-30 |
Piramal Enterprises Limited |
A process for the preparation of valacyclovir hydrochloride
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
US20140100238A1
(en)
|
2012-10-04 |
2014-04-10 |
Ohio State University |
Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
|
|
US20140213600A1
(en)
*
|
2013-01-29 |
2014-07-31 |
Lily Hsiao |
Medicament for treating peripheral neuropathies
|
|
TW201429475A
(zh)
*
|
2013-01-29 |
2014-08-01 |
Li-Ly Hsiao |
使用抗病毒藥治療末稍神經病變之疾病
|
|
SG11201600919UA
(en)
|
2013-08-27 |
2016-03-30 |
Gilead Pharmasset Llc |
Combination formulation of two antiviral compounds
|
|
CN115745997A
(zh)
*
|
2022-11-30 |
2023-03-07 |
湖北省宏源药业科技股份有限公司 |
一种高纯度伐昔洛韦杂质h制备方法
|